Literature DB >> 9203968

Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis.

S A McDonald1, M J Palmen, E P Van Rees, T T MacDonald.   

Abstract

One of the major advances in the understanding of inflammatory bowel disease has been the observation that mice with immunoregulatory defects, such as interleukin-2 knockout (IL-2 -/-) mice, develop spontaneous gut inflammation. Here we have characterized the immune response in the ileum, caecum and colon of these mice before and after the onset of colitis by examining the cellular infiltrate, the cytokines produced by these cells and the mucosal vascular addressin MAdCAM-1. IL-2 -/- mice developed colitis after 35 days of age and before this the mice were apparently healthy. IL-2 -/- mice aged over 35 days with colitis had large numbers of CD4+, CD8+, alpha beta T-cell receptor (TCR)+ and gamma delta TCR+ T cells, macrophages, dendritic cells and MAdCAM-1+ endothelial cells in the caecum and colon. This was associated with an increase in the number of interferon-gamma (IFN-gamma), IL-1 and tumour necrosis factor-alpha (TNF-alpha) transcripts and a decrease in IL-4 and IL-10 transcripts. Treatment of IL-2 -/- mice with cyclosporin A significantly delayed mortality. Interestingly, IL-2 -/- mice under 35 days, although healthy, did show some subtle immunological signs of preclinical disease. There was a significant increase in the number of macrophages and dendritic cells in the colonic lamina propria and increased mRNA for IL-1 and TNF-alpha. There were also increased numbers of MAdCAM-1+ endothelial cells, but IFN-gamma transcripts were not elevated. These results suggest that T-cell-mediated colitis in IL-2 -/- mice may be secondary to an initial non-specific inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203968      PMCID: PMC1364037          DOI: 10.1046/j.1365-2567.1997.00217.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

2.  Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice.

Authors:  P Mombaerts; E Mizoguchi; M J Grusby; L H Glimcher; A K Bhan; S Tonegawa
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

3.  The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1.

Authors:  E E Sikorski; R Hallmann; E L Berg; E C Butcher
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

4.  Role of intestinal microflora in chronic inflammation and ulceration of the rat colon.

Authors:  S Videla; J Vilaseca; F Guarner; A Salas; F Treserra; E Crespo; M Antolín; J R Malagelada
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

5.  Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis.

Authors:  M J Palmen; L A Dieleman; M B van der Ende; A Uyterlinde; A S Peña; S G Meuwissen; E P van Rees
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

6.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

7.  TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation.

Authors:  N W Lukacs; R M Strieter; S W Chensue; M Widmer; S L Kunkel
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

8.  Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes.

Authors:  D J Erle; M J Briskin; E C Butcher; A Garcia-Pardo; A I Lazarovits; M Tidswell
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

9.  Gut-homing CD4+ T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease.

Authors:  A Rudolphi; G Boll; S S Poulsen; M H Claesson; J Reimann
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

Review 10.  Free radicals in inflammatory bowel diseases pathophysiology and therapeutic implications.

Authors:  V Gross; H Arndt; T Andus; K D Palitzsch; J Schölmerich
Journal:  Hepatogastroenterology       Date:  1994-08
View more
  21 in total

1.  Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease.

Authors:  S Dionne; S Laberge; C Deslandres; E G Seidman
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 2.  Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.

Authors:  Saskia Thomas; Daniel C Baumgart
Journal:  Inflammopharmacology       Date:  2011-12-20       Impact factor: 4.473

3.  Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.

Authors:  D W Hommes; T L Mikhajlova; S Stoinov; D Stimac; B Vucelic; J Lonovics; M Zákuciová; G D'Haens; G Van Assche; S Ba; S Lee; T Pearce
Journal:  Gut       Date:  2006-02-28       Impact factor: 23.059

Review 4.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.

Authors:  L M Higgins; G Frankel; G Douce; G Dougan; T T MacDonald
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production.

Authors:  M Waidmann; Y Allemand; J Lehmann; S di Genaro; N Bücheler; A Hamann; I B Autenrieth
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

7.  Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD).

Authors:  S Bregenholt; M H Claesson
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

8.  Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease.

Authors:  H S Souza; C C Elia; J Spencer; T T MacDonald
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

9.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

10.  Rheostat regulation of integrin-mediated leukocyte adhesion.

Authors:  Ivor S Douglas; Themistocles Dassopoulos
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.